Status:
COMPLETED
Mental Health Among Patients, Providers, and Staff During the COVID-19 Era
Lead Sponsor:
St. Luke's Health System, Boise, Idaho
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Idaho Crisis & Suicide Hotline
Conditions:
Covid19
Mental Health
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
The Mental Health Among Patients, Providers, and Staff (MHAPPS) Study is designed to study how the COVID-19 pandemic has affected mental health and wellbeing, and how to support mental health while mi...
Detailed Description
Approximately 4,800 participants will complete the Aim 1 survey. The Caring Contacts intervention involves sending a series of brief, non-demanding, supportive text messages to the participant. One in...
Eligibility Criteria
Inclusion
- Aim 1:
- Provider \& Employee Inclusion Criteria
- Provider or Employee at St. Luke's Health System
- Adults ≥ 18 years of age
- Proficient in spoken and written English language
- Patient Inclusion Criteria
- Patient at a St. Luke's Health System primary care site
- Current MyChart account user
- Adults ≥18 years of age
- Minors 12-17 years of age
- Proficient in spoken and written English language
- Aim 2:
- Provider \& Employee Inclusion Criteria
- Moderate or high score for loneliness, suicide ideation, psychological stress, anxiety, or depression:
- NIH Toolkit Loneliness raw score of 13 or greater or
- C-SSRS score of 3 or greater; or
- NIH Toolkit Perceived Stress raw score of 31 or greater for adults; or
- GAD7 score of 11 or greater; or
- PHQ9 score of 10 or greater
- Access to a phone for the duration of the study with the ability to receive text messages and phone calls
- Patient Inclusion Criteria
- Moderate or high score for loneliness, suicide ideation, psychological stress, anxiety, or depression:
- NIH Toolkit Loneliness raw score of 13 or greater for adults or 16 or greater for adolescents; or
- C-SSRS score of 3 or greater; or
- GAD7 score of 11 or greater; or
- PHQ9 score of 10 or greater; or
- NIH Toolkit Stress raw score of 31 or greater for adults or 33 or greater for adolescents
- \[Note: validated youth versions of the NIH Toolkit assessments (loneliness and perceived stress), and PHQ-A tools will be used for adolescents; the C-SSRS and GAD7 tools are validated for use with both adults and adolescents.\]
- Access to a phone for the duration of the study with the ability to receive text messages and phone calls
Exclusion
- Aim 1:
- Provider \& Employee Exclusion Criteria
- Individuals who are unable or unwilling to provide informed consent to participate
- Individuals who are study staff for this study or the SPARC Trial
- Patient Exclusion Criteria
- Individuals who are unable or unwilling to provide informed consent to participate.
- Individuals who are participants in the SPARC Trial
- Individuals who have not had a primary care visit in the past 12 months
- Aim 2:
- Provider \& Employee Exclusion Criteria
- Individuals who are unable or unwilling to provide informed consent to participate
- Individuals who are in acute crisis as determined by the person conducting the consent process
- Individuals who are study staff for this study or the SPARC Trial
- Individuals who are enrolled as participants in the SPARC comparative effectiveness clinical trial (SPARC Aim 1). Providers or employees who received training related to SPARC and/or who completed the SPARC provider satisfaction survey are not excluded from participating in MHAPPS
- Patient Exclusion Criteria
- Patients who are unable or unwilling to provide informed consent/assent to participate (or whose legally authorized representative is unable or unwilling to provide consent in the case of adolescents). Examples may include but are not limited to patients who present with acute or chronic cognitive impairment that would preclude their ability to consent (i.e. acute psychosis, intoxication, or intellectual disability).
Key Trial Info
Start Date :
January 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2022
Estimated Enrollment :
666 Patients enrolled
Trial Details
Trial ID
NCT04700137
Start Date
January 18 2021
End Date
January 6 2022
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Luke's Health System
Boise, Idaho, United States, 83712